Regulating Medicines in Europe
Competition, Expertise and Public Health
- Publisher's listprice GBP 32.99
-
15 760 Ft (15 010 Ft + 5% VAT)
The price is estimated because at the time of ordering we do not know what conversion rates will apply to HUF / product currency when the book arrives. In case HUF is weaker, the price increases slightly, in case HUF is stronger, the price goes lower slightly.
- Discount 20% (cc. 3 152 Ft off)
- Discounted price 12 608 Ft (12 008 Ft + 5% VAT)
Subcribe now and take benefit of a favourable price.
Subscribe
15 760 Ft
Availability
Estimated delivery time: In stock at the publisher, but not at Prospero's office. Delivery time approx. 3-5 weeks.
Not in stock at Prospero.
Why don't you give exact delivery time?
Delivery time is estimated on our previous experiences. We give estimations only, because we order from outside Hungary, and the delivery time mainly depends on how quickly the publisher supplies the book. Faster or slower deliveries both happen, but we do our best to supply as quickly as possible.
Product details:
- Edition number 1
- Publisher Routledge
- Date of Publication 28 September 2000
- ISBN 9780415208789
- Binding Paperback
- No. of pages256 pages
- Size 216x138 mm
- Weight 470 g
- Language English
- Illustrations 9 Tables, black & white 0
Categories
Short description:
This book presents a critical appraisal of medicines regulation policy and exposes the influence of the pharmaceutical industry in the acceleration of drug approvals.
MoreLong description:
This Book explains and investigates how medicines are controlled in Europe, especially the EU. Based on penetrating documentary and interview research with the pharmaceutical industry, regulators and consumer organisations,it provides the first major critical examination of the new Europeanised systems of medicine regulation. The authors argue that the drive to produce and approve more drugs more quickly for a single European market dominates other considerations, such as improvements in democratic accountability, the independence of regulators and scientific expertise from commercial interests, and drug safety testing and surveillance.
MoreTable of Contents:
Introduction; Chapter 1 Science, technology and regulation; Chapter 2 Opening the black box of European medicines regulation; Chapter 3 National regulation in Europe; Chapter 4 The Europeanisation of medicines regulation; Chapter 5 The politics of scientific expertise; Chapter 6 Competition, harmonisation and public health; Chapter 7 Democracy, technocracy and secrecy; Chapter 8 Conclusions and political implications;
More
Lexikon zum Steuerrecht, m. CD-ROM
5 350 HUF
5 082 HUF
